The critical role of IL-13 in the IgE production and the eosinophilic pathway, along with the association between IL-13 and asthma severity, led to a shift in focus of the pharmaceutical society to the development of anti-IL-13 agents to treat asthma [16]. This evidence concerns the gene IL13 and asthma.